MedTrace Logo

Molecular Mechanisms Underlying Prostate Cancer Disparities

NCT02229565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 226

Last updated 2020-11-13

No results posted yet for this study

Summary

The purpose of this study is to further elucidate the molecular mechanisms underlying prostate cancer disparities. In previous work the investigators have identified a set of differentially deregulated genes in African American versus Caucasian American prostate cancer. Based on these findings, they hypothesize that they will be able to validate these targets, originally identified in the previous work conducted at The George Washington University Medical Center, in an independent Duke University Medical Center cohort of prostate cancer specimens. In addition, the investigators hypothesize that they will be able to discover novel targets in the Duke University Medical Center cohort of prostate cancer specimens because of regional differences.

Conditions

Interventions

DEVICE

Biopsy or prostatectomy

Sponsors & Collaborators

Principal Investigators

  • Steven Patierno, PhD · Duke University

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2019-10-14
Completion
2019-10-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02229565 on ClinicalTrials.gov